Cookie policy

This site uses cookies to improve your user experience. By using this website, you agree that we can place cookies on your device. For further information, please read our Privacy And Cookies Policy

I accept the terms and conditions
Skip Ribbon Commands
Skip to main content


Safety Hypodermic Needles


The SurGuard™2 needle has been developed to meet the market’s requirements and offers you a simple SAFETY solution.

It's simple locking mechanism will minimize needle stick injuries significantly and can easily be activated by using only one hand!

The SurGuard™2 needle’s standard hub equally fits to all luer lock and luer slip syringes compliant with EN ISO 80369-7.


​Simple injections

Engineered for user convenience and patient comfort, SurGuard™2 Safety Hypodermic Needles feature T-SharpTM technology.
Designed for subcutaneous, intramuscular and intravenous injections, SurGuard™2 Safety Hypodermic Needles offer the necessary quality and supply reliability drug developers need to meet parenteral delivery challenges and product commercialization goals. 

Convenient administration

  • Simplified, one-handed activation for most injection modalities1
  • Stable, reliable, hinged sheath provides audible, visible and tangible confirmation of activation1
  • Thin wall2, low inner-diameter needles with proven performance2  
  • Sheath locks around the needle for security post-administration 
  • Designed to reduce penetration resistance and injection drag forces
  • Selectable sheath position pre-administration to suit user-preference
  • Minimum training required

Engineered for automated environments

  • Soft blister with colour tags and UDI information - allowing full device identification by on-line-vision-systems 
  • Available in a wide variety of diameters and lenghts suitable to specify most drug applications and combinations

Regulatory and Quality Aspects

  • Suited for both Luer slip tip and Luer Lock syringes compliant with EN ISO 80369-7
  • In compliance with applicable ISO standards and Pharmacopoeia
  • Proven track record of reliable supply assured by global operating company 

General specifications

​​SurGuard™ 2 Safety Hypodermic Needles are intended for subcutaneous, intramuscular and intravenous applications.

Specification Description
Needle PointT-SharpTM Triple-bevel lancet point
CannulasStainless steel X5CrNi 18-10
HubPolypropylene + Color Masterbatch
Shipping carton (standard packaging)800 pcs (8 X 100 pcs)
Shelf-life5 years

Global Solutions

​SurGuard™2 Safety Hypodermic Needles are available to drug product manufacturers globally. For more information about product availability, specifications, and applicable standards, download our data sheet or contact your Terumo representative today.

Please note that some products may not be available in all regions, reach out to your local Terumo Medical Care Solutions - Pharmaceutical Solutions Division contact for details. All brand names are trademarks or registered trademarks owned by TERUMO CORPORATION, its affiliates, or unrelated third parties.


Relevant product information
SG2 Leaflet_TMCS_2023


​1 Data on file 
Valid for cannula gauges from 18G to 25G/16mm

Let’s Find Your Best Solution

Innovation and creativity are central to our Pharmaceutical Solutions Division value proposition. Our expert teams lead the industry in developing and manufacturing advanced, high-performing infusion and injection technologies for all parenteral applications.

Contact Us

Didn't find your product?

Consult our products in our Product Index

Are you a pharmaceutical professional?

This information is intended for professionals in the pharmaceutical supply chain who are interested in primary packaging, injection components and medical devices from Terumo Pharmaceutical Solutions, for use in combination with their respective drug products (hereafter, pharmaceutical professionals). Please note that the product information contained on this website is exclusively addressed to pharmaceutical professionals. This product information is not for the general public, nor is it intended to be a substitute for professional medical advice or for the care that patients receive from their healthcare professionals. By accessing it, you (i) acknowledge having read and understood both the above message and our terms of use and, further, (ii) confirm that you do so in the capacity of a pharmaceutical professional.